(Q37731624)

22 August 2017

1 reference

title

Addressing barriers to initiation of insulin in patients with type 2 diabetes (English)

1 reference

22 August 2017

0 references

0 references

1 reference

3

1 reference

22 August 2017

Mark Peyrot

1

1 reference

PubMed ID

20394886

22 August 2017

Richard R Rubin

series ordinal

2

1 reference

22 August 2017

1 April 2010

1 reference

22 August 2017

Primary Care Diabetes

1 reference

22 August 2017

4 Suppl 1

1 reference

22 August 2017

S11-8

1 reference

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group

22 August 2017

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

10-year follow-up of intensive glucose control in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Effect of intensive control of glucose on cardiovascular outcomes and death in patients with diabetes mellitus: a meta-analysis of randomised controlled trials

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Management of hyperglycemia in type 2 diabetes: A consensus algorithm for the initiation and adjustment of therapy: a consensus statement from the American Diabetes Association and the European Association for the Study of Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Systematic review: comparative effectiveness and safety of premixed insulin analogues in type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Pharmacokinetic and pharmacodynamic advantages of insulin analogues and premixed insulin analogues over human insulins: impact on efficacy and safety

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Efficacy and safety of insulin detemir

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Safety and side effects of the insulin analogues

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Delayed initiation of subcutaneous insulin therapy after failure of oral glucose-lowering agents in patients with Type 2 diabetes: a population-based analysis in the UK.

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Delay of insulin addition to oral combination therapy despite inadequate glycemic control: delay of insulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

The IMPROVE study--a multinational, observational study in type 2 diabetes: baseline characteristics from eight national cohorts

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

When oral agents fail: practical barriers to starting insulin

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Psychological insulin resistance in patients with type 2 diabetes: the scope of the problem

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Assessing psychosocial distress in diabetes: development of the diabetes distress scale

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Psychological insulin resistance: patient beliefs and implications for diabetes management

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Psychological insulin resistance: overcoming barriers to starting insulin therapy

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Insulin omission in women with IDDM.

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Primary care physician beliefs about insulin initiation in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers.

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

How doctors choose medications to treat type 2 diabetes: a national survey of specialists and academic generalists.

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Behavioral and psychosocial interventions in diabetes: a conceptual review

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Tailoring nicotine addiction treatments for chemical dependency patients.

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Development and validation of the insulin treatment appraisal scale (ITAS) in patients with type 2 diabetes.

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets - the TITRATE study

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Initiating insulin therapy in type 2 diabetes: benefits of insulin analogs and insulin pens

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

FlexPen for the delivery of insulin: accuracy, injection force and patient preference

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

A multicenter, randomized, open-label, comparative, two-period crossover trial of preference, efficacy, and safety profiles of a prefilled, disposable pen and conventional vial/syringe for insulin injection in patients with type 1 or 2 diabetes mell

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

A comparison of the handling and accuracy of syringe and vial versus prefilled insulin pen (FlexPen)

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Interventions to improve the management of diabetes mellitus in primary care, outpatient and community settings

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

US nurses' perceptions of their role in diabetes care: results of the cross-national Diabetes Attitudes Wishes and Needs (DAWN) study

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Impact of automated calls with nurse follow-up on diabetes treatment outcomes in a Department of Veterans Affairs Health Care System: a randomized controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Shifting of care for diabetes from secondary to primary care, 1990-5: review of general practices

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Who looks after people with diabetes: primary or secondary care?

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Quality of diabetes care in the UK: comparison of published quality-of-care reports with results of the Quality and Outcomes Framework for Diabetes

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

Effects of quality improvement strategies for type 2 diabetes on glycemic control: a meta-regression analysis

1 reference

https://api.crossref.org/works/10.1016%2FS1751-9918%2810%2960004-6

7 January 2021

10.1016/S1751-9918(10)60004-6

Identifiers

DOI

1 reference

22 August 2017

1 reference

PubMed ID

20394886